Talha Khan Burki. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useBenzamides/adverse effectsBenzamides/therapeutic useHumansLeukemia, Lymphocytic, Chronic, B-Cell/drug therapyPyrazines/adverse effectsPyrazines/therapeutic useRecurrenceRetreatment
Substances: See more » Antineoplastic AgentsBenzamidesPyrazinesacalabrutinib
Year: 2015 PMID: 26710712 DOI: 10.1016/S1470-2045(15)00610-5
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 41.316